Eposis 10000IU/ml Injection

Eposis is also utilized in reducing the need for allogeneic blood transfusions in surgical patients and in certain cases of HIV-related anemia. The administration of Eposis should be individualized based on hemoglobin levels and patient response, with careful monitoring to avoid excessive erythropoiesis and associated risks such as hypertension and thromboembolic events. Dosage adjustments are necessary in accordance with clinical response and hemoglobin targets, typically aiming to maintain hemoglobin levels sufficient to reduce transfusion requirements without exceeding recommended thresholds.

Eposis is administered via subcutaneous or intravenous injection under medical supervision. Contraindications include uncontrolled hypertension and hypersensitivity to the active substance or any excipients. Caution is advised in patients with cardiovascular risk factors. Proper storage conditions and handling must be observed to maintain product stability and efficacy.